Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient

dc.contributor.authorOlivé i Plana, Montserrat
dc.contributor.authorShatunov, Alexey
dc.contributor.authorGonzález Mera, Laura
dc.contributor.authorCarmona, Olga
dc.contributor.authorMoreno, Dolores
dc.contributor.authorGonzález Quereda, Lidia
dc.contributor.authorMartínez Matos, Juan Antonio
dc.contributor.authorGoldfarb, Lev G.
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.date.accessioned2018-11-30T12:38:41Z
dc.date.available2018-11-30T12:38:41Z
dc.date.issued2008-12
dc.date.updated2018-07-25T10:40:36Z
dc.description.abstractA 27-year-old woman of Moldavian origin presented at the age of 15 with progressive proximal limb weakness and painful cramps in her calf muscles. Clinical examination revealed prominent Muscle weakness in proximal muscles of the lower extremities and distal anterior compartment of legs, and mild weakness in shoulder girdle muscles. In addition, she had marked calf hypertrophy, Muscle atrophy involving the anterior and posterior compartments of the thighs, and the distal anterior compartment of legs, as well as mild scapular winging and hyperlordosis. A muscle biopsy taken from the biceps brachii showed mild dystrophic changes, absent vacuoles, and abundant lobulated fibers. Immunofluorescence and Western blot assays demonstrated complete telethonin deficiency. Molecular analysis revealed a homozygous Trp25X mutation in the telethonin (TCAP) gene resulting in termination of transcription at an early point. Four families from Brazil with telethonin deficiency have previously been reported and classified as LMD2G, but the actual frequency of this disease is unknown. With this current identification of a case outside the Brazilian Population, telethonin mutation-associated LGMD should be considered worldwide. (C) 2008 Elsevier B.V. All rights reserved.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid18948002
dc.identifier.urihttps://hdl.handle.net/2445/126631
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.nmd.2008.07.009
dc.relation.ispartofNeuromuscular Disorders, 2008, vol. 18, num. 12, p. 929-933
dc.relation.urihttps://doi.org/10.1016/j.nmd.2008.07.009
dc.rights(c) Elsevier, 2008
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationHipertròfia
dc.subject.classificationImmunofluorescència
dc.subject.otherHypertrophy
dc.subject.otherImmunofluorescence
dc.titleTranscription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
OliveM.pdf
Mida:
584.58 KB
Format:
Adobe Portable Document Format